Comparative efficacy and safety of teriparatide versus bisphosphonates in osteoporosis: a meta-analysis.

Front Surg · 2025 · PMC12719462 · PMID 41438698

Europe PMC DOI

hedged sentences

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

did not reach statistical significancep = 0.11not close (p > 0.1)

However, the pooled effect did not reach statistical significance [OR = 0.41, 95% CI: (0.14, 1.21), p = 0.11], and heterogeneity remained low (I 2 = 35%).

also in 111,027 other papers

showed a trendno p-value reported

When compared with alendronate, teriparatide showed a trend toward reducing vertebral fracture risk.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.